| Bioactive self-nanoemulsifying drug delivery systems (Bio-SNEDDS) for combined oral delivery of curcumin and piperine M Kazi, AA Shahba, S Alrashoud, M Alwadei, AY Sherif, FK Alanazi Molecules 25 (7), 1703, 2020 | 74 | 2020 |
| Evaluation of the bioavailability of hydrocortisone when prepared as solid dispersion MA Altamimi, EM Elzayat, W Qamar, SM Alshehri, AY Sherif, N Haq, ... Saudi pharmaceutical journal 27 (5), 629-636, 2019 | 39 | 2019 |
| Novel in-situ gel for intravesical administration of ketorolac AY Sherif, GM Mahrous, FK Alanazi Saudi Pharmaceutical Journal 26 (6), 845-851, 2018 | 37 | 2018 |
| Zingerone (4-(four-hydroxy-3-methylphenyl) butane-two-1) modulates adjuvant-induced rheumatoid arthritis by regulating inflammatory cytokines and antioxidants N Bashir, SB Ahmad, MU Rehman, S Muzamil, RR Bhat, MR Mir, ... Redox Report 26 (1), 62-70, 2021 | 26 | 2021 |
| Bacteriosomes as a promising tool in biomedical applications: immunotherapy and drug delivery GI Harisa, AY Sherif, AME Youssof, FK Alanazi, MM Salem-Bekhit AAPS PharmSciTech 21 (5), 168, 2020 | 24 | 2020 |
| Engineering of exosomes: steps towards green production of drug delivery system AY Sherif, GI Harisa, FK Alanazi, AME Youssof Current Drug Targets 20 (15), 1537-1549, 2019 | 23 | 2019 |
| Optimization of gefitinib-loaded nanostructured lipid carrier as a biomedical tool in the treatment of metastatic lung cancer AY Sherif, GI Harisa, AA Shahba, FK Alanazi, W Qamar Molecules 28 (1), 448, 2023 | 21 | 2023 |
| PEGylated SLN as a promising approach for lymphatic delivery of gefitinib to lung cancer AY Sherif, GI Harisa, FK Alanazi, FA Nasr, AS Alqahtani International Journal of Nanomedicine 17, 3287, 2022 | 21 | 2022 |
| Combined Ramipril and Black Seed Oil Dosage Forms Using Bioactive Self-Nanoemulsifying Drug Delivery Systems (BIO-SNEDDSs) AAW Shahba, AY Sherif, EM Elzayat, M Kazi Pharmaceuticals 15 (9), 1120, 2022 | 16 | 2022 |
| Engineered nanoscale lipid-based formulation as potential enhancer of gefitinib lymphatic delivery: cytotoxicity and apoptotic studies against the A549 cell line AY Sherif, GI Harisa, FK Alanazi, FA Nasr, AS Alqahtani AAPS PharmSciTech 23 (6), 183, 2022 | 15 | 2022 |
| Development and evaluation of interactive flipped e-learning (ifeel) for pharmacy students during the covid-19 pandemic AA Shahba, Z Alashban, I Sales, AY Sherif, O Yusuf International Journal of Environmental Research and Public Health 19 (7), 3902, 2022 | 13 | 2022 |
| Hybrid lymphatic drug delivery vehicles as a new avenue for targeted therapy: Lymphatic trafficking, applications, challenges, and future horizons GI Harisa, AY Sherif, FK Alanazi The Journal of Membrane Biology 256 (3), 199-222, 2023 | 12 | 2023 |
| Formulation and evaluation of fluconazole mucoadhisive vaginal tablets GM Mahours, A Sherif, D Shaaban, G Shazly BJPR 14 (2), 1-10, 2016 | 11 | 2016 |
| Development of a Multifunctional Oral Dosage Form via Integration of Solid Dispersion Technology with a Black Seed Oil-Based Self-Nanoemulsifying Drug Delivery System AY Sherif, AAW Shahba Biomedicines 11 (10), 2733, 2023 | 9 | 2023 |
| TPGS decorated NLC shift gefitinib from portal absorption into lymphatic delivery: Intracellular trafficking, biodistribution and bioavailability studies GI Harisa, AY Sherif, FK Alanazi, EA Ali, GA Omran, FA Nasr, SM Attia, ... Colloids and Surfaces B: Biointerfaces 223, 113148, 2023 | 9 | 2023 |
| Gene-editing technology, from macromolecule therapeutics to organ transplantation: Applications, limitations, and prospective uses GI Harisa, TM Faris, AY Sherif, RF Alzhrani, SA Alanazi, NA Kohaf, ... International Journal of Biological Macromolecules, 127055, 2023 | 8 | 2023 |
| Enhanced Codelivery of Gefitinib and Azacitidine for Treatment of Metastatic-Resistant Lung Cancer Using Biodegradable Lipid Nanoparticles EM Elzayat, AY Sherif, FA Nasr, MW Attwa, DH Alshora, SF Ahmad, ... Materials 16 (15), 5364, 2023 | 8 | 2023 |
| Coding therapeutic nucleic acids from recombinant proteins to next-generation vaccines: Current uses, limitations, and future horizons GI Harisa, TM Faris, AY Sherif, RF Alzhrani, SA Alanazi, NA Kohaf, ... Molecular Biotechnology 66 (8), 1853-1871, 2024 | 5 | 2024 |
| Assembly of nanostructured lipid carriers loaded gefitinib and simvastatin as hybrid therapy for metastatic breast cancer: Codelivery and repurposing approach AY Sherif, GI Harisa, AA Shahba, FA Nasr, EI Taha, AS Alqahtani Drug Development Research 84 (7), 1453-1467, 2023 | 5 | 2023 |
| SLN mediate active delivery of gefitinib into A549 cell line: Optimization, biosafety and cytotoxicity studies AY Sherif, GI Harisa, FK Alanazi Drug Delivery Letters 13 (2), 133-150, 2023 | 5 | 2023 |
